News

January 6, 2016

Malignant Mesothelioma Cells Respond to Combination Therapy in Lab

News

In a new study, researchers showed both in vivo and in vitro that a combination therapy of a chemotherapeutic drug and an IL-1R antagonist could be a beneficial treatment strategy for ... Read more

January 4, 2016January 6, 2016

Calretinin Found to Affect Proliferation and Mobility Rates of Mouse Mesothelial Cells

News

In a new study, researchers at the University of Fribourg and University Hospital Zürich have demonstrated calretinin’s possible role in mesothelial cells’ mobility and proliferation as well as in the development ... Read more

December 29, 2015December 29, 2015

Inherited Mesothelioma-causing Mutation May Link 80,000 People to 1 Immigrant Couple

News

A new study suggests that as many as 80,000 Americans, all thought to be descendants of an immigrant couple, may be at higher risk for mesothelioma because of a genetic mutation ... Read more

December 22, 2015December 23, 2015

Mesothelioma-associated BAP1 Mutation Found in Four Related Families

News

In a new study, researchers from the University of Hawaii identified an inherited cancer syndrome known to be associated with high incidence of mesothelioma, uveal melanoma, and other cancers. The ... Read more

December 21, 2015December 21, 2015

Mesothelioma Treatment and Other Needs Linked to 9/11 Attacks Funded by Congress

News

The U.S. Congress recently extended the Zadroga Act, offering healthcare benefits to all 9/11 responders involved in rescue operations and others requiring medical monitoring and treatments for injuries related to exposure to harmful agents and pollutants following the terror ... Read more

December 18, 2015December 21, 2015

Malignant Pleural Mesothelioma Patients Seen to Do Best with Surgery as Therapy

News

In a new study, researchers analyzed the mesothelioma patient cases present in the large SEER database to study the effect of prognosis factors, especially the type of therapy chosen, in survival ... Read more

December 18, 2015December 18, 2015

Detecting and Treating Mesothelioma via Mesothelin Expression Is Goal of New Partnership

News

Morphotek, Inc., a biopharmaceutical company and Eisai subsidiary that develops antibody and protein products through gene evolution technology, and Biocare Medical, LLC, announced a license agreement to develop a new immunohistochemical ... Read more

December 17, 2015December 17, 2015

Peritoneal Mesothelioma Case Diagnosed Using Non-invasive Method

News

A new case study reports the successful diagnosis of peritoneal mesothelioma by endoscopic ultrasound (EUS)-guided tissue acquisition and fine-needle aspiration (FNA), a less invasive method than that commonly used. The ... Read more

December 17, 2015December 17, 2015

CT Scans Used to Distinguish Malignant Peritoneal Mesothelioma from Tuberculous Peritonitis

News

A new report from researchers in China suggests that CT scanning may be useful for identifying peritoneal mesothelioma. The study, titled “CT differentiation of malignant peritoneal mesothelioma and tuberculous peritonitis,” ... Read more

December 15, 2015December 15, 2015

Study Of Amatuximab For First-Line, Unresectable, Malignant Pleural Mesothelioma Patients Launched

News

Exton, Pennsylvania based Morphotek, Inc., the U.S. biopharmaceutical subsidiary of Tokyo-based global health care pharmaceutical company Eisai Co.,Ltd. — specializing in development of protein and antibody products through use of novel ... Read more